Business
DECN Announces Distribution Agreement Covering GenViro! Covid-19:10.5 Swift Kits and Its GenUltimate and TGB Products in India, Malaysia, Sri Lanka, Singapore, Indonesia, Thailand, Vietnam, Nepal, Bangladesh and Australia
DECN Announces Distribution Agreement Covering GenViro! Covid-19:10.5 Swift Kits and Its GenUltimate and TGB Products in India, Malaysia, Sri Lanka, Singapore, Indonesia, Thailand, Vietnam, Nepal, Bangladesh and Australia.
About this update from Decision Diagnostics Corp
[{"type":"text","content":"COMPANY ALSO ANNOUNCES IT IS CURRENTLY EVALUATING ADDITIONAL AGREEMENTS FOR DISTRIBUTION OF GENVIRO! SWIFT KITS IN BRAZIL, ARGENTINA, NIGERIA AND THE PHILIPPINES, AND THAT IT HAS FILED A PROVISIONAL PATENT FOR ITS GENULTIMATE TBG PRODUCTLOS ANGELES, CA / ACCESSWIRE / July 8, 2020 / Decision Diagnostics Corp. (OTC PINK:DECN) through its subsidiary Pharma Tech Solutions, Inc., today announced it has entered into a written distribution agreement for its GenViro! Covid-19 10.5 Second Swift Kit and other products with Global Swift Sensor Distribution, who will represent the company's GenViro! and GenUltimate products on a non-exclusive but first-to-market basis in India, Sri Lanka, Singapore, Malaysia, Indonesia, Thailand, Vietnam, Nepal, Bangladesh and Australia. The company also said it is evaluating two additional distribution offers from Brazil and Argentina (as a combined distributorship) as well as separate proposals for distributorships in Nigeria and the Philippines with the Nigeria distributorship closer to completion.The company plans to manufacture two GenViro! International Covid-19 Swift Kit packages for sale in Central and Southern Asia and reports that its new distributor will be opening hubs in Singapore, India and Australia. The distributor has agreed to have these hubs managed locally by equity personnel selected specifically for their knowledge and experience in dealing with the national and local governments where the GenViro! Swift Kit will be available. The company still estimates that sales for its International GenViro! Swift Kits will commence in late Summer 2020. The new distributorship has agreed to buy the GenViro! and GenUltimate products in international packaging and their particular product requests are now being initiated by the company."While we have remained in regular contact with the U.S. FDA and are looking toward an authorization for our GenViro! Covid-19 :10.5 Swift Kits to permit sales in the United States and Puerto Rico, the company has conducted and continues to conduct appropriate testing, and has been busy assembling the network of distributors and relationships internationally to bring our critically needed Covid-19 testing to these foreign markets. Finally, we are almost there," said Keith Berman CEO of DECN. "We are seeing huge interest in the GenViro! Swift Kit from...